drugset / Trial / NCT00642122

Adults With Moderate to Severe Asthma

NCT00642122 ↗

Phase 3 Completed 900 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindTreatment

Summary

A study to compare the safety and effectiveness of 5 different ways of taking Pulmicort when given to asthma patients aged 12 years and above.

Timeline

Start
2003-04
Primary completion
2004-12
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 4 ug —
Subject Budesonide Small molecule 0.5 mg —
Subject Budesonide Small molecule 1 mg —
Subject Budesonide Small molecule 2 mg —

Indications